ROBIN TURINETTI: Open Payments
NPI 1285973453 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,406 in 45 payments from 13 companies in 2025. Trend: 2023 $7,364 · 2024 $3,384 · 2025 $3,406
Food & beverage: $1,532Speaker / faculty: $1,520Travel & lodging: $337Education: $17
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 8 | $2,069 |
| AstraZeneca Pharmaceuticals LP | 11 | $540 |
| JAZZ PHARMACEUTICALS INC. | 2 | $159 |
| GlaxoSmithKline, LLC. | 8 | $156 |
| Novo Nordisk Inc | 1 | $125 |
| Verona Pharma, Inc. | 3 | $77 |
| Insmed, Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| United Therapeutics Corporation | 1 | $34 |
Products named: Prolastin-C Liquid, BREZTRI, AIRSUPRA, XYWAV, Ozempic, FASENRA, NUCALA, Ohtuvayre.
Industry payments across FL — which companies pay providers there.
